COVID-19: Avoiding culture shock with the SARS-CoV-2 spike protein
When culturing SARS-CoV-2 in the laboratory it is vital to avoid deletions in the gene for the spike protein that could affect the interpretation of experiments.
- Institute of Medical Virology, University of Zurich, Switzerland
Researchers across the globe are frantically trying to understand the biology of different SARS-CoV-2 variants to develop new therapeutics and bring the COVID-19 pandemic to an end. The process begins in the laboratory, with painstaking experiments to judge whether a drug can stop SARS-CoV-2 from replicating in cells in a dish, or whether a vaccine can stop an animal from getting sick. But such experiments require copious amounts of SARS-CoV-2, and the authenticity of that virus stock (which is usually cultured in animal cell lines) is paramount to ensure the validity of test results.
The standard 'go-to' cells for producing stocks of SARS-CoV-2 are derived from the Vero lineage (which are kidney cells isolated from an African green monkey almost 60 years ago). These cells are highly susceptible to viruses due to the absence of type I interferon cytokines, an important group of signaling proteins released by cells in the presence of viruses. Vero cells are a popular choice for isolating and propagating many viruses because they are well characterized and easy to maintain, they adhere to laboratory dishes, and they show visible structural changes when infected. However, like viruses circulating naturally in human populations, viruses grown in the laboratory also have a tendency to change and adapt to the environment that they are in.
An early study, since replicated by others, found that SARS-CoV-2 stocks cultured in Vero-derived cells often harbor mutations or deletions in the spike gene (Lau et al., 2020). The deletions remove an important region on the spike protein, called the multibasic cleavage site, which affects the ability of the virus to infect human airway cells (Hoffmann et al., 2020; Mykytyn et al., 2021; Pohl et al., 2021). Such viruses therefore do not behave like authentic SARS-CoV-2 in several aspects: they are less pathogenic (Johnson et al., 2021; Lau et al., 2020); they do not transmit (Peacock et al., 2021); and they exhibit altered sensitivities to inhibition by antiviral interferon-stimulated genes and patient antibodies (Johnson et al., 2021; Winstone et al., 2021).
These characteristics can make it difficult to interpret laboratory experiments that use Vero-produced viruses to assess the effectiveness of experimental drugs or vaccines. The ability of inactivated SARS-CoV-2 vaccines made in Vero cells to stimulate correct antibody responses might also be partially compromised, although this has not been formally assessed (Gao et al., 2020; Wang et al., 2020). Now, in eLife, Bart Haagmans and colleagues of the Erasmus Medical Center in Rotterdam and the University of Illinois at Urbana-Champaign – including Mart Lamers as first author – report simple methods for producing SARS-CoV-2 stocks in human cells that prevent such mutations and deletions in the gene for the spike protein (Figure 1; Lamers et al., 2021).
Figure 1
Culturing SARS-CoV-2 in Vero cells and human cells.
Schematic representation of a human SARS-CoV-2 patient sample passaged using the Vero cell line (which was isolated from an African green monkey almost 60 years ago; top), or the Calu-3 cell line (which is a human cell line; bottom). Vero cells are deficient in a serine protease called TMPRSS2 that is needed for the virus to enter cells at the plasma membrane; however, certain SARS-CoV-2 variants with spike deletions (shown in red) can enter Vero cells via a different pathway, so these variants are artificially selected for and come to dominate the virus population. The pathogenicity, transmission properties, and sensitivity to antiviral drugs and antibodies of the variants are different to those of the wild-type virus. Calu-3 cells are not deficient in TMPRSS2, so the authenticity of the spike gene is maintained, and studies with such virus stocks more faithfully recapitulate human virus biology.
Figure created with BioRender.com.
First, Lamers et al. used a method called deep sequencing to confirm that repeated culture of SARS-CoV-2 in Vero cells leads to an increase in viral genomes with mutations or deletions in the important region of the spike gene. Less sensitive sequencing methods, or a reliance on 'consensus sequences', can leave researchers with the false impression that such deletions are absent.
Lamers et al. then pinpointed how these spike deletions give certain SARS-CoV-2 variants a replicative advantage in Vero cells, which enables them to dominate the virus population. Vero cells are deficient in a serine protease that is needed for SARS-CoV-2 to enter human airway cells at the plasma membrane: however, SARS-CoV-2 variants with the spike gene deletions exploit a different pathway (called endocytosis) to enter Vero cells. It seems the ability of the variants to take advantage of this second entry route allows them to dominate when Vero cells are used.
Lamers et al. next asked whether a human-airway cell line, Calu-3, might be a better alternative to culture SARS-CoV-2, given that this cell line possesses the necessary protease (Mykytyn et al., 2021). Indeed, they found that repeated culture of SARS-CoV-2 in Calu-3 cells (or Vero cells engineered to express the serine protease) prevented the accumulation of mutations and deletions in the SARS-CoV-2 spike. Moreover, Calu-3 cells were as good as Vero cells at producing the large amounts of virus necessary for further experiments. Thus, the authentic nature of SARS-CoV-2 stocks made in this way, as assessed by deep sequencing, will give confidence to the interpretation of subsequent experiments.
The results from this study make a compelling case for SARS-CoV-2 researchers to thoroughly characterize the genomic sequences of the virus stocks they produce (and to avoid consensus sequencing). Furthermore, researchers should consider the cells, the growth media and the additives used for virus production to prevent artefactual SARS-CoV-2 culture adaptations that might impact the evaluation of drug or vaccine effectiveness.
Cell culture systems to propagate viruses are the linchpin of virology, yet they have not really changed since the beginnings of the field. The application of modern technological advances, such as rational gene editing of cells or the use of in vivo-like organoid tissue models, promises to transform this critical aspect of virology and should allow researchers to update their methods to maintain experimental authenticity.
References
-
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junctionEmerging Microbes & Infections 9:837–842.https://doi.org/10.1080/22221751.2020.1756700
Article and author information
Author details
Publication history
Copyright
© 2021, Hale
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,305
- views
-
- 164
- downloads
-
- 8
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
COVID-19: Avoiding culture shock with the SARS-CoV-2 spike protein
eLife 10:e69496.
https://doi.org/10.7554/eLife.69496
Further reading
-
- Microbiology and Infectious Disease
Because of high mutation rates, viruses constantly adapt to new environments. When propagated in cell lines, certain viruses acquire positively charged amino acids on their surface proteins, enabling them to utilize negatively charged heparan sulfate (HS) as an attachment receptor. In this study, we used enterovirus A71 (EV-A71) as the model and demonstrated that, unlike the parental MP4 variant, the cell-adapted strong HS-binder MP4-97R/167 G does not require acidification for uncoating and releases its genome in the neutral or weakly acidic environment of early endosomes. We experimentally confirmed that this pH-independent entry is not associated with the use of HS as an attachment receptor but rather with compromised capsid stability. We then extended these findings to another HS-dependent strain. In summary, our data indicate that the acquisition of capsid mutations conferring affinity for HS comes together with decreased capsid stability and allows EV-A71 to enter the cell via a pH-independent pathway. This pH-independent entry mechanism boosts viral replication in cell lines but may prove deleterious in vivo, especially for enteric viruses crossing the acidic gastric environment before reaching their primary replication site, the intestine. Our study thus provides new insight into the mechanisms underlying the in vivo attenuation of HS-binding EV-A71 strains. Not only are these viruses hindered in tissues rich in HS due to viral trapping, as generally accepted, but our research reveals that their diminished capsid stability further contributes to attenuation in vivo. This underscores the complex relationship between HS-binding, capsid stability, and viral fitness, where increased replication in cell lines coincides with attenuation in harsh in vivo environments like the gastrointestinal tract.
-
- Genetics and Genomics
- Microbiology and Infectious Disease
Tgt is the enzyme modifying the guanine (G) in tRNAs with GUN anticodon to queuosine (Q). tgt is required for optimal growth of Vibrio cholerae in the presence of sub-lethal aminoglycoside concentrations. We further explored here the role of the Q34 in the efficiency of codon decoding upon tobramycin exposure. We characterized its impact on the overall bacterial proteome, and elucidated the molecular mechanisms underlying the effects of Q34 modification in antibiotic translational stress response. Using molecular reporters, we showed that Q34 impacts the efficiency of decoding at tyrosine TAT and TAC codons. Proteomics analyses revealed that the anti-SoxR factor RsxA is better translated in the absence of tgt. RsxA displays a codon bias toward tyrosine TAT and overabundance of RsxA leads to decreased expression of genes belonging to SoxR oxidative stress regulon. We also identified conditions that regulate tgt expression. We propose that regulation of Q34 modification in response to environmental cues leads to translational reprogramming of transcripts bearing a biased tyrosine codon usage. In silico analysis further identified candidate genes which could be subject to such translational regulation, among which DNA repair factors. Such transcripts, fitting the definition of modification tunable transcripts, are central in the bacterial response to antibiotics.
